Ascendis Pharma (ASND) PT Raised to $260 at JPMorgan
Tweet Send to a Friend
(Updated - August 20, 2025 8:25 AM EDT)
JPMorgan analyst Jessica Fye raised the price target on Ascendis Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Jessica Fye raised the price target on Ascendis Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
